BM567 is a sulfonylurea compound (compound 1), which exhibits antithrombogenic efficacy as thromboxane A 2 receptor ( TXR ) antagonists and thromboxane A 2 synthase ( TXS ) inhibitors, with IC 50 s of 1.1 and 12 nM, respectively.
Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Prostaglandin Receptor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.